Novel adeno-associated viral vector delivering the utrophin gene regulator jazz counteracts dystrophic pathology in mdx mice

Georgios Strimpakos, Nicoletta Corbi, Cinzia Pisani, Maria Grazia Di Certo, Annalisa Onori, Siro Luvisetto, Cinzia Severini, Francesca Gabanella, Lucia Monaco, Elisabetta Mattei, Claudio Passananti

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Over-expression of the dystrophin-related gene utrophin represents a promising therapeutic strategy for Duchenne muscular dystrophy (DMD). The strategy is based on the ability of utrophin to functionally replace defective dystrophin. We developed the artificial zinc finger transcription factor "Jazz" that up-regulates both the human and mouse utrophin promoter. We observed a significant recovery of muscle strength in dystrophic Jazz-transgenic mdx mice. Here we demonstrate the efficacy of an experimental gene therapy based on the systemic delivery of Jazz gene in mdx mice by adeno-associated virus (AAV). AAV serotype 8 was chosen on the basis of its high affinity for skeletal muscle. Muscle-specific expression of the therapeutic Jazz gene was enhanced by adding the muscle α-actin promoter to the AAV vector (mAAV). Injection of mAAV8-Jazz viral preparations into mdx mice resulted in muscle-specific Jazz expression coupled with up-regulation of the utrophin gene. We show a significant recovery from the dystrophic phenotype in mAAV8-Jazz-treated mdx mice. Histological and physiological analysis revealed a reduction of fiber necrosis and inflammatory cell infiltration associated with functional recovery in muscle contractile force. The combination of ZF-ATF technology with the AAV delivery can open a new avenue to obtain a therapeutic strategy for treatment of DMD.

Original languageEnglish
Pages (from-to)1283-1291
Number of pages9
JournalJournal of Cellular Physiology
Volume229
Issue number9
DOIs
Publication statusPublished - 2014

Fingerprint

Utrophin
Inbred mdx Mouse
Dependovirus
Pathology
Regulator Genes
Muscle
Genes
Viruses
Muscles
Dystrophin
Duchenne Muscular Dystrophy
Up-Regulation
Recovery
Investigational Therapies
Zinc Fingers
Muscle Strength
Therapeutics
Genetic Therapy
Transgenic Mice
Actins

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Cell Biology
  • Physiology

Cite this

Strimpakos, G., Corbi, N., Pisani, C., Di Certo, M. G., Onori, A., Luvisetto, S., ... Passananti, C. (2014). Novel adeno-associated viral vector delivering the utrophin gene regulator jazz counteracts dystrophic pathology in mdx mice. Journal of Cellular Physiology, 229(9), 1283-1291. https://doi.org/10.1002/jcp.24567

Novel adeno-associated viral vector delivering the utrophin gene regulator jazz counteracts dystrophic pathology in mdx mice. / Strimpakos, Georgios; Corbi, Nicoletta; Pisani, Cinzia; Di Certo, Maria Grazia; Onori, Annalisa; Luvisetto, Siro; Severini, Cinzia; Gabanella, Francesca; Monaco, Lucia; Mattei, Elisabetta; Passananti, Claudio.

In: Journal of Cellular Physiology, Vol. 229, No. 9, 2014, p. 1283-1291.

Research output: Contribution to journalArticle

Strimpakos, G, Corbi, N, Pisani, C, Di Certo, MG, Onori, A, Luvisetto, S, Severini, C, Gabanella, F, Monaco, L, Mattei, E & Passananti, C 2014, 'Novel adeno-associated viral vector delivering the utrophin gene regulator jazz counteracts dystrophic pathology in mdx mice', Journal of Cellular Physiology, vol. 229, no. 9, pp. 1283-1291. https://doi.org/10.1002/jcp.24567
Strimpakos, Georgios ; Corbi, Nicoletta ; Pisani, Cinzia ; Di Certo, Maria Grazia ; Onori, Annalisa ; Luvisetto, Siro ; Severini, Cinzia ; Gabanella, Francesca ; Monaco, Lucia ; Mattei, Elisabetta ; Passananti, Claudio. / Novel adeno-associated viral vector delivering the utrophin gene regulator jazz counteracts dystrophic pathology in mdx mice. In: Journal of Cellular Physiology. 2014 ; Vol. 229, No. 9. pp. 1283-1291.
@article{d296edb5194240e5b1a425c788f72f51,
title = "Novel adeno-associated viral vector delivering the utrophin gene regulator jazz counteracts dystrophic pathology in mdx mice",
abstract = "Over-expression of the dystrophin-related gene utrophin represents a promising therapeutic strategy for Duchenne muscular dystrophy (DMD). The strategy is based on the ability of utrophin to functionally replace defective dystrophin. We developed the artificial zinc finger transcription factor {"}Jazz{"} that up-regulates both the human and mouse utrophin promoter. We observed a significant recovery of muscle strength in dystrophic Jazz-transgenic mdx mice. Here we demonstrate the efficacy of an experimental gene therapy based on the systemic delivery of Jazz gene in mdx mice by adeno-associated virus (AAV). AAV serotype 8 was chosen on the basis of its high affinity for skeletal muscle. Muscle-specific expression of the therapeutic Jazz gene was enhanced by adding the muscle α-actin promoter to the AAV vector (mAAV). Injection of mAAV8-Jazz viral preparations into mdx mice resulted in muscle-specific Jazz expression coupled with up-regulation of the utrophin gene. We show a significant recovery from the dystrophic phenotype in mAAV8-Jazz-treated mdx mice. Histological and physiological analysis revealed a reduction of fiber necrosis and inflammatory cell infiltration associated with functional recovery in muscle contractile force. The combination of ZF-ATF technology with the AAV delivery can open a new avenue to obtain a therapeutic strategy for treatment of DMD.",
author = "Georgios Strimpakos and Nicoletta Corbi and Cinzia Pisani and {Di Certo}, {Maria Grazia} and Annalisa Onori and Siro Luvisetto and Cinzia Severini and Francesca Gabanella and Lucia Monaco and Elisabetta Mattei and Claudio Passananti",
year = "2014",
doi = "10.1002/jcp.24567",
language = "English",
volume = "229",
pages = "1283--1291",
journal = "Journal of cellular and comparative physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "9",

}

TY - JOUR

T1 - Novel adeno-associated viral vector delivering the utrophin gene regulator jazz counteracts dystrophic pathology in mdx mice

AU - Strimpakos, Georgios

AU - Corbi, Nicoletta

AU - Pisani, Cinzia

AU - Di Certo, Maria Grazia

AU - Onori, Annalisa

AU - Luvisetto, Siro

AU - Severini, Cinzia

AU - Gabanella, Francesca

AU - Monaco, Lucia

AU - Mattei, Elisabetta

AU - Passananti, Claudio

PY - 2014

Y1 - 2014

N2 - Over-expression of the dystrophin-related gene utrophin represents a promising therapeutic strategy for Duchenne muscular dystrophy (DMD). The strategy is based on the ability of utrophin to functionally replace defective dystrophin. We developed the artificial zinc finger transcription factor "Jazz" that up-regulates both the human and mouse utrophin promoter. We observed a significant recovery of muscle strength in dystrophic Jazz-transgenic mdx mice. Here we demonstrate the efficacy of an experimental gene therapy based on the systemic delivery of Jazz gene in mdx mice by adeno-associated virus (AAV). AAV serotype 8 was chosen on the basis of its high affinity for skeletal muscle. Muscle-specific expression of the therapeutic Jazz gene was enhanced by adding the muscle α-actin promoter to the AAV vector (mAAV). Injection of mAAV8-Jazz viral preparations into mdx mice resulted in muscle-specific Jazz expression coupled with up-regulation of the utrophin gene. We show a significant recovery from the dystrophic phenotype in mAAV8-Jazz-treated mdx mice. Histological and physiological analysis revealed a reduction of fiber necrosis and inflammatory cell infiltration associated with functional recovery in muscle contractile force. The combination of ZF-ATF technology with the AAV delivery can open a new avenue to obtain a therapeutic strategy for treatment of DMD.

AB - Over-expression of the dystrophin-related gene utrophin represents a promising therapeutic strategy for Duchenne muscular dystrophy (DMD). The strategy is based on the ability of utrophin to functionally replace defective dystrophin. We developed the artificial zinc finger transcription factor "Jazz" that up-regulates both the human and mouse utrophin promoter. We observed a significant recovery of muscle strength in dystrophic Jazz-transgenic mdx mice. Here we demonstrate the efficacy of an experimental gene therapy based on the systemic delivery of Jazz gene in mdx mice by adeno-associated virus (AAV). AAV serotype 8 was chosen on the basis of its high affinity for skeletal muscle. Muscle-specific expression of the therapeutic Jazz gene was enhanced by adding the muscle α-actin promoter to the AAV vector (mAAV). Injection of mAAV8-Jazz viral preparations into mdx mice resulted in muscle-specific Jazz expression coupled with up-regulation of the utrophin gene. We show a significant recovery from the dystrophic phenotype in mAAV8-Jazz-treated mdx mice. Histological and physiological analysis revealed a reduction of fiber necrosis and inflammatory cell infiltration associated with functional recovery in muscle contractile force. The combination of ZF-ATF technology with the AAV delivery can open a new avenue to obtain a therapeutic strategy for treatment of DMD.

UR - http://www.scopus.com/inward/record.url?scp=84901227909&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901227909&partnerID=8YFLogxK

U2 - 10.1002/jcp.24567

DO - 10.1002/jcp.24567

M3 - Article

VL - 229

SP - 1283

EP - 1291

JO - Journal of cellular and comparative physiology

JF - Journal of cellular and comparative physiology

SN - 0021-9541

IS - 9

ER -